Global Peritoneal Dialysis Market

Peritoneal Dialysis Market Size, Share, Growth Analysis, By Product Type(CAPD, APD), By Product(Cyclers, Fluids), By End User(Home Health Care, Hospitals) - Industry Forecast 2024-2031


Report ID: SQMIG35D2183 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 87 | Figures: 77

Peritoneal Dialysis Market Insights

Global Peritoneal Dialysis Market size was valued at USD 76.9 billion in 2019 and is poised to grow from USD 81.8 billion in 2023 to USD 126.43 billion by 2031, growing at a CAGR of 6.4% in the forecast period (2024-2031).

When your kidneys are no longer able to effectively complete the job, peritoneal dialysis is a treatment option. Compared to hemodialysis, which is a more popular blood-filtering method, this process filters the blood in a different way. A cleaning solution is injected into a portion of your abdomen via a catheter during peritoneal dialysis. Your peritoneum, which lines your belly, functions as a filter to take waste materials out of your blood. The fluid containing the filtered waste items flows out of your abdomen and is expelled after a certain amount of time. One of the treatments for kidney failure with the quickest rate of growth is peritoneal dialysis (PD), which is preferable for patients who still have some renal function and can tolerate the rapid changes in fluid balance brought on by hemodialysis. PD provides flexible treatment options and minimizes trips to the dialyzer. The advantages of choosing PD home dialysis include improved outcomes, fewer drugs, and fewer dietary restrictions. Patients may simply check themselves at all times when doing peritoneal dialysis at home without help. These benefits have increased the popularity of PD among renal patients today and will continue to support the peritoneal dialysis market throughout the projected period.

The majority of older patients with end-stage renal illness receiving PD therapy have varying degrees of accessibility, expertise, and technical education. Many older cycler patients' aversion to using them and their technophobia is seen as commercial limitations. Patients with end-stage kidney disease (ESKD) lasting fewer than two years had a rise in home dialysis use from 14.8 percent in 2023 to 20.0 percent in 2019, with PD accounting for more than 90% of total use. The use of home dialysis increased from 11.7 percent in 2023 to 13.7 percent in 2019 among patients with ESKD lasting 2 to 4 years. The increase in dialysis is expected to boost the growth of the global peritoneal dialysis market during the forecast period.

The global peritoneal dialysis market had been severely disrupted by the COVID-19 pandemic. Due to pandemic's high hospitalization rates, the need for dialysis equipment and supplies has suddenly increased. The greater frequency of coexisting diseases including CKD, diabetes, and hypertension was primarily to blame for this. The epidemic also caused significant supply-chain disruptions, which made it difficult for producers to keep up with demand. The ageing population's increasing medical demands, the increased demand for novel goods and treatments, and developments in medical technology are all predicted to contribute to the market's continued expansion after COVID-19. Additionally, increasing governmental and commercial sector initiatives to promote home HD/PD may open up more lucrative market prospects after COVID-19.

US Peritoneal Dialysis Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Peritoneal Dialysis Market size was valued at USD 76.9 billion in 2019 and is poised to grow from USD 81.8 billion in 2023 to USD 126.43 billion by 2031, growing at a CAGR of 6.4% in the forecast period (2024-2031).

The peritoneal dialysis market is relatively fragmented, with a high level of competition. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. For example, to enhance the patient treatment experience and for better overall results, Medtronic, a pioneer in healthcare technology, has partnered with DaVita's extensive experience as a provider of comprehensive kidney care. Together, they plan to establish a new independent medical device company called "NewCo," with a focus on kidneys. For patients with renal failure, NewCo will be positioned as an advanced firm of discovery and distinctive therapeutics. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective solutions. ' Baxter B. Braun Melsungen AG Fresenius Medical Care AG & Co. KGaA Medtronic plc Terumo Corporation Cook Medical Inc. Utah Medical Products Inc. Cardinal Health Inc. Poly Medicure Limited Diversified Specialty Institute Holdings Inc. Renax Biomedical Tech Co. Ltd. Renal Solutions Inc. Vygon SA Merit Medical Systems Inc. Huaren Pharmaceutical Co. Ltd. Nikkiso Co. Ltd. Nephros Inc. Covidien plc AngioDynamics Inc. Q Core Medical Ltd. ', 'Baxter', 'B. Braun Melsungen AG', 'Fresenius Medical Care AG & Co. KGaA', 'Medtronic plc', 'Terumo Corporation', 'Cook Medical Inc.', 'Utah Medical Products Inc.', 'Cardinal Health Inc.', 'Poly Medicure Limited', 'Diversified Specialty Institute Holdings Inc.', 'Renax Biomedical Tech Co. Ltd.', 'Renal Solutions Inc.', 'Vygon SA', 'Merit Medical Systems Inc.', 'Huaren Pharmaceutical Co. Ltd.', 'Nikkiso Co. Ltd.', 'Nephros Inc.', 'Covidien plc', 'AngioDynamics Inc.', 'Q Core Medical Ltd.'

During the projected period, factors like rising end-stage renal disease (ESRD) prevalence, technical advancements in peritoneal dialysis cyclers, and rising demand for home dialysis treatment is anticipated to propel the growth of the peritoneal dialysis market. Peritoneal dialysis also has several benefits, including lower costs compared to hemodialysis, needle-free therapy, mobility, ease of treatment, and fewer dietary restrictions, which all contribute to the market's expansion internationally.

The primary growth drivers of the peritoneal dialysis market are increase in the prevalence of End Stage Renal Disease (ESRD), increase in the number of patients with acute diabetes and high blood pressure, increased public awareness of peritoneal dialysis, increased government initiatives globally, and an increase in the demand for technologically advanced treatment methods. Additionally, growing peritoneal dialysis use in developing nations like China, India, and others would open up new prospects for the peritoneal dialysis market.

With a market share of more than 35.0 percent and the highest revenue in 2021, North America dominated the peritoneal dialysis market. The region's market is expanding as a result of the existence of important players, large government expenditures in the creation of cutting-edge medical devices, and a favorable reimbursement environment. Dialysis is becoming more popular as a result of the increase in kidney failures and chronic kidney diseases (CKD). High disposable income, government efforts, and rising healthcare spending are a few major reasons boosting the industry.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Peritoneal Dialysis Market

Product ID: SQMIG35D2183

$5,300
BUY NOW GET FREE SAMPLE